| |
Euthyroid Group
II (n=39) |
Hypothyroid Group I
(n=10) |
p-value |
| Age |
59.7±11.4 |
62.9±7.7 |
0.332 |
T
T3/T4 |
37 (95%) |
10 (100%) |
1.000 |
N
N0
N+ |
30 (77%)
9 (23%) |
8 (80%)
2 (20%) |
1.000 |
Closure Technique
Staple
Suture |
9 (23%)
30 (77%) |
2 (20%)
8 (80%) |
1.000 |
| TEP |
27 (69%) |
7 (70%) |
1.000 |
| CP Myotomy |
20 (51%) |
7 (70%) |
0.478 |
| Thyroidectomy |
11 (28%) |
2 (20%) |
0.710 |
| Flap Closure |
11 (28%) |
5 (50%) |
0.261 |
| Revision Surgery |
9 (23%) |
3 (30%) |
0.690 |
| Degree Diff |
36 (92%) |
9 (90%) |
1.000 |
| Positive Margin |
3 (8%) |
2 (20%) |
0.267 |
| Infection |
7 (18%) |
2 (20%) |
1.000 |
| Fistula |
14 (36%) |
4 (40%) |
1.000 |
| Misc Surg Compl |
8 (21%) |
0 (0%) |
0.180 |
| Tob |
32 (82%) |
8 (80%) |
1.000 |
| EtOH |
26 (67%) |
4 (40%) |
0.157 |
| Illicit Drugs |
3 (8%) |
0 (0%) |
1.000 |
| Diabetes |
7 (18%) |
2 (20%) |
1.000 |
| TPN/PEG ≥ 2 wks |
18 (46%) |
4/8 (50%) |
1.000 |
| Pre-op XRT |
10 (26%) |
7 (70%) |
0.021 |
| Post-op XRT |
23 (59%) |
2 (20%) |
0.037 |
| Chemotherapy |
6/37 (16%) |
4/9 (44%) |
0.087 |
| EBL |
372.8±291.1 |
341.7±204.6 |
0.846 |
| PKYr |
63.7±33.2 |
91.3±29.2 |
0.040 |
| TSH value |
1.6±0.8 |
7.2±6.8 |
0.0007 |
| Pre Albumin |
13.3±5.5 |
13.4±4.6 |
0.837 |
| Albumin |
3.8±0.7 |
2.9±0.8 |
0.010 |
| Hgb |
13.4±2.2 |
12.5±2.3 |
0.297 |
All p-values are based on Fisher’s exact tests for categorical risk factors, and
Wilcoxon rank-sum tests for continuous risk factors
Legend: TEP = Tracheoesophageal puncture, CP = cricopharyngeal, Degree Diff
= moderately and poorly differentiated, Misc Surg Compl = miscellaneous surgical
complications, Tob = tobacco use > 20 pack years, EtOH = alcohol abuse, TPN/
PEG = total parenteral nutrition/percutaneous enteral gastrostomy tube, XRT =
radiation, EBL = estimated blood loss, PK Yr = pack year, TSH = thyroid stimulating
hormone, Hgb = hemoglobin |
